With insulin price cap, drug industry is once again shamed into doing the right thing – Los Angeles Times
The United States doesn’t have a market-based economy for prescription drugs. It has a shame-based economy. The latest example of this “scarlet letter” approach to drug pricing came this week as insurance giant Cigna and its Express Scripts subsidiary announced that consumers with drug benefits managed by the company could …